| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTB
|
actin, beta
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
ANXA5
|
annexin A5
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARR3
|
arrestin 3, retinal (X-arrestin)
|
|
ASCC1
|
activating signal cointegrator 1 complex subunit 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
B2M
|
beta-2-microglobulin
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L10
|
BCL2-like 10 (apoptosis facilitator)
|
|
BCL2L2
|
BCL2-like 2
|
|
BCL2L2-PABPN1
|
BCL2L2-PABPN1 readthrough
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRD2
|
bromodomain containing 2
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
BYSL
|
bystin-like
|
|
C6ORF25
|
chromosome 6 open reading frame 25
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CCAR1
|
cell division cycle and apoptosis regulator 1
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNT1
|
cyclin T1
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD109
|
CD109 molecule
|
|
CD163
|
CD163 molecule
|
|
CD19
|
CD19 molecule
|
|
CD22
|
CD22 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD37
|
CD37 molecule
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD70
|
CD70 molecule
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
|
|
CES2
|
carboxylesterase 2
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRDL1
|
chordin-like 1
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
CIB2
|
calcium and integrin binding family member 2
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CMA1
|
chymase 1, mast cell
|
|
COMMD1
|
copper metabolism (Murr1) domain containing 1
|
|
COX2
|
|
|
CRBN
|
cereblon
|
|
CREBBP
|
CREB binding protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CUL4B
|
cullin 4B
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
D2HGDH
|
D-2-hydroxyglutarate dehydrogenase
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DNER
|
delta/notch-like EGF repeat containing
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOHH
|
deoxyhypusine hydroxylase/monooxygenase
|
|
DTX3L
|
deltex 3 like, E3 ubiquitin ligase
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
E2F1
|
E2F transcription factor 1
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELL3
|
elongation factor RNA polymerase II-like 3
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EP300
|
E1A binding protein p300
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETFA
|
electron-transfer-flavoprotein, alpha polypeptide
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV6
|
ets variant 6
|
|
EXOC2
|
exocyst complex component 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASN
|
fatty acid synthase
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FHIT
|
fragile histidine triad
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOXM1
|
forkhead box M1
|
|
FOXN3
|
forkhead box N3
|
|
FOXO1
|
forkhead box O1
|
|
FOXO4
|
forkhead box O4
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GATA2
|
GATA binding protein 2
|
|
GBA
|
glucosidase, beta, acid
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GLI1
|
GLI family zinc finger 1
|
|
GMCL1
|
germ cell-less, spermatogenesis associated 1
|
|
GOT2
|
glutamic-oxaloacetic transaminase 2, mitochondrial
|
|
GPX4
|
glutathione peroxidase 4
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
H2AX
|
H2A.X variant histone
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC6
|
histone deacetylase 6
|
|
HDAC9
|
histone deacetylase 9
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIP1R
|
huntingtin interacting protein 1 related
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HPGDS
|
hematopoietic prostaglandin D synthase
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPH1
|
heat shock 105kDa/110kDa protein 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGH
|
immunoglobulin heavy locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL17A
|
interleukin 17A
|
|
IL17D
|
interleukin 17D
|
|
IL1A
|
interleukin 1, alpha
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL21R
|
interleukin 21 receptor
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL24
|
interleukin 24
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL31RA
|
interleukin 31 receptor A
|
|
IL34
|
interleukin 34
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL9
|
interleukin 9
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF8
|
interferon regulatory factor 8
|
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JCHAIN
|
joining chain of multimeric IgA and IgM
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2B
|
lysine (K)-specific demethylase 2B
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KDSR
|
3-ketodihydrosphingosine reductase
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
KL
|
klotho
|
|
KLHDC8B
|
kelch domain containing 8B
|
|
KLHL6
|
kelch-like family member 6
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2B
|
lysine (K)-specific methyltransferase 2B
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT20
|
keratin 20, type I
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGMN
|
legumain
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LMNA
|
lamin A/C
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
LOC102724971
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
LTA
|
lymphotoxin alpha
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L2
|
MAD2 mitotic arrest deficient-like 2 (yeast)
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MCAT
|
malonyl CoA:ACP acyltransferase (mitochondrial)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEF2B
|
myocyte enhancer factor 2B
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIXL1
|
Mix paired-like homeobox
|
|
MLH1
|
mutL homolog 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MME
|
membrane metallo-endopeptidase
|
|
MRPL28
|
mitochondrial ribosomal protein L28
|
|
MRPL58
|
mitochondrial ribosomal protein L58
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH3
|
mutS homolog 3
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MSN
|
moesin
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTSS1
|
metastasis suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MXD1
|
MAX dimerization protein 1
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYDGF
|
myeloid-derived growth factor
|
|
MZB1
|
marginal zone B and B1 cell-specific protein
|
|
NAPRT
|
nicotinate phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEK2
|
NIMA-related kinase 2
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NLRP2
|
NLR family, pyrin domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NXT1
|
nuclear transport factor 2-like export factor 1
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14
|
|
PARP9
|
poly (ADP-ribose) polymerase family, member 9
|
|
PCDH10
|
protocadherin 10
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PER3
|
period circadian clock 3
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PIAS2
|
protein inhibitor of activated STAT, 2
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLK1
|
polo-like kinase 1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
PPA1
|
pyrophosphatase (inorganic) 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM11
|
PR domain containing 11
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAG3
|
protein kinase, AMP-activated, gamma 3 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
RAD1
|
RAD1 checkpoint DNA exonuclease
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RANGAP1
|
Ran GTPase activating protein 1
|
|
RASGRP4
|
RAS guanyl releasing protein 4
|
|
RBL1
|
retinoblastoma-like 1
|
|
RDX
|
radixin
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RHOA
|
ras homolog family member A
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RNF34
|
ring finger protein 34, E3 ubiquitin protein ligase
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SDC1
|
syndecan 1
|
|
SERPINA9
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
|
|
SIK2
|
salt-inducible kinase 2
|
|
SIRT1
|
sirtuin 1
|
|
SLAMF7
|
SLAM family member 7
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC22A2
|
solute carrier family 22 (organic cation transporter), member 2
|
|
SLC7A4
|
solute carrier family 7, member 4
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD1
|
SMAD family member 1
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SPART
|
spartin
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SPN
|
sialophorin
|
|
SPOP
|
speckle-type POZ protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRR1A
|
small proline-rich protein 1A
|
|
SRM
|
spermidine synthase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
SUB1
|
SUB1 homolog (S. cerevisiae)
|
|
SYK
|
spleen tyrosine kinase
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAT
|
tyrosine aminotransferase
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCL1B
|
T-cell leukemia/lymphoma 1B
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPM3
|
tropomyosin 3
|
|
TRA
|
T cell receptor alpha locus
|
|
TRB
|
T cell receptor beta locus
|
|
TRIM13
|
tripartite motif containing 13
|
|
TSPAN33
|
tetraspanin 33
|
|
TXN
|
thioredoxin
|
|
UBR1
|
ubiquitin protein ligase E3 component n-recognin 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
USP34
|
ubiquitin specific peptidase 34
|
|
UVRAG
|
UV radiation resistance associated
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WTAP
|
Wilms tumor 1 associated protein
|
|
XBP1
|
X-box binding protein 1
|
|
XCR1
|
chemokine (C motif) receptor 1
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YY1
|
YY1 transcription factor
|
|
ZACN
|
zinc activated ligand-gated ion channel
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZC3H12D
|
zinc finger CCCH-type containing 12D
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|